• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Systemic absorption and cardiovascular effects of phenylephrine eyedrops.

作者信息

Kumar V, Schoenwald R D, Chien D S, Packer A J, Choi W W

出版信息

Am J Ophthalmol. 1985 Feb 15;99(2):180-4. doi: 10.1016/0002-9394(85)90229-6.

DOI:10.1016/0002-9394(85)90229-6
PMID:3970123
Abstract

We studied 24 patients undergoing vitreoretinal surgery to compare the systemic absorption and cardiovascular effects of 2.5% aqueous and 10% viscous ophthalmic solutions of phenylephrine hydrochloride. Plasma levels measured in patients receiving two drops of 10% viscous solution were consistently higher ten, 20, and 60 minutes after instillation (P less than .02). Although the mean systolic and diastolic blood pressure was generally higher with the 10% viscous solution, the difference was not statistically significant. Blood pressure was high in several isolated cases. Because maximum plasma levels are achieved within ten to 20 minutes after topical instillation, phenylephrine eyedrops should be administered under close observation so that if an adverse reaction occurs it can be readily treated.

摘要

相似文献

1
Systemic absorption and cardiovascular effects of phenylephrine eyedrops.
Am J Ophthalmol. 1985 Feb 15;99(2):180-4. doi: 10.1016/0002-9394(85)90229-6.
2
Aqueous vs viscous phenylephrine. I. Systemic absorption and cardiovascular effects.
Arch Ophthalmol. 1986 Aug;104(8):1189-91. doi: 10.1001/archopht.1986.01050200095058.
3
Cardiovascular Adverse Effects of Phenylephrine Eyedrops: A Systematic Review and Meta-analysis.苯肾上腺素滴眼液的心血管不良影响:系统评价和荟萃分析。
JAMA Ophthalmol. 2015 Jun;133(6):647-52. doi: 10.1001/jamaophthalmol.2015.0325.
4
Lack of side effects from topically administered 10% phenylephrine eyedrops. A controlled study.
Arch Ophthalmol. 1980 Mar;98(3):487-9. doi: 10.1001/archopht.1980.01020030483009.
5
Cardiac effects of different eyedrop preparations of timolol in rabbits.
Curr Eye Res. 1992 May;11(5):469-73. doi: 10.3109/02713689209001801.
6
Controlled retrospective study of the effects of eyedrops containing phenylephrine hydrochloride and scopolamine hydrobromide on mean arterial blood pressure in anesthetized dogs.含盐酸去氧肾上腺素和氢溴酸东莨菪碱滴眼液对麻醉犬平均动脉血压影响的对照回顾性研究。
Am J Vet Res. 2010 Dec;71(12):1407-12. doi: 10.2460/ajvr.71.12.1407.
7
High-precision piezo-ejection ocular microdosing: Phase II study on local and systemic effects of topical phenylephrine.
Ther Deliv. 2018 Jan;9(1):17-27. doi: 10.4155/tde-2017-0095. Epub 2017 Oct 27.
8
Effect of combined 1% cyclopentolate-10% phenylephrine eye drops on systemic blood pressure of glaucoma patients.
Ann Ophthalmol. 1981 Jun;13(6):735-6.
9
The phenylephrine concentration-response relationship for blood pressure after nasal delivery in children.儿童鼻腔给药后苯肾上腺素对血压的浓度-反应关系。
Paediatr Anaesth. 2017 Oct;27(10):1050-1055. doi: 10.1111/pan.13221. Epub 2017 Sep 4.
10
Topical 2.5% and 5% phenylephrine: comparison of effects on heart rate and blood pressure.局部用2.5%和5%去氧肾上腺素:对心率和血压影响的比较。
Can J Ophthalmol. 1990 Dec;25(7):336-9.

引用本文的文献

1
Safety of tropicamide and phenylephrine in pupillary mydriasis for cataract surgery.用于白内障手术瞳孔散大的托吡卡胺和去氧肾上腺素的安全性。
Saudi J Ophthalmol. 2022 Feb 18;35(2):108-111. doi: 10.4103/1319-4534.337859. eCollection 2021 Apr-Jun.
2
Effect of Topical Phenylephrine 2.5% on Episcleral Venous Pressure in Normal Human Eyes.局部应用 2.5%苯肾上腺素对正常人眼巩膜静脉压的影响。
Invest Ophthalmol Vis Sci. 2021 Oct 4;62(13):4. doi: 10.1167/iovs.62.13.4.
3
Adverse Cardiovascular Effects of Phenylephrine Eye Drops Combined With Intravenous Atropine.
去氧肾上腺素滴眼液联合静脉注射阿托品的心血管不良影响。
Front Pharmacol. 2021 Jan 27;11:596539. doi: 10.3389/fphar.2020.596539. eCollection 2020.
4
Hemodynamic Changes Associated with Mydriatic Eye Drop Administration in Anesthetized Pediatric Patients.麻醉状态下儿科患者使用散瞳滴眼液后的血流动力学变化
Ocul Oncol Pathol. 2020 May;6(3):203-209. doi: 10.1159/000500593. Epub 2019 Oct 30.
5
Intraocular administration of tetramethylpyrazine hydrochloride to rats: a direct delivery pathway for brain targeting?盐酸川芎嗪经大鼠眼内给药:脑靶向的直接递送途径?
Drug Deliv. 2019 Dec;26(1):841-848. doi: 10.1080/10717544.2019.1650849.
6
Potential cardiovascular adverse events when phenylephrine is combined with paracetamol: simulation and narrative review.去氧肾上腺素与对乙酰氨基酚联合使用时潜在的心血管不良事件:模拟与叙述性综述
Eur J Clin Pharmacol. 2015 Aug;71(8):931-8. doi: 10.1007/s00228-015-1876-1. Epub 2015 May 29.
7
Comparative study measuring the dilatory effect of a mydriatic device (Mydriasert(®)) versus topical drops.比较研究测量一种散瞳装置(Mydriasert(®))与局部滴眼液的散瞳效果。
Int J Ophthalmol. 2013 Dec 18;6(6):801-4. doi: 10.3980/j.issn.2222-3959.2013.06.11. eCollection 2013.
8
Use of a new ocular insert versus conventional mydriasis in cataract surgery.在白内障手术中使用新型眼部植入物与传统散瞳的比较。
Biomed Res Int. 2013;2013:849349. doi: 10.1155/2013/849349. Epub 2013 May 30.
9
Effect of 10% phenylephrine eye drops on systemic blood pressure in normotensive & hypertensive patient.10%去氧肾上腺素滴眼液对血压正常及高血压患者全身血压的影响。
Oman Med J. 2009 Jan;24(1):30-2. doi: 10.5001/omj.2009.8.
10
Ocular phenylephrine 2.5% continues to be dangerous.
BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.08.2008.0795. Epub 2009 Mar 2.